Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1LWD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,237
Award facts
- Contract value 100% obligated
- $11,236.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,236.71 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count units) on November 25, 2025. This firm fixed-price, non-competitive delivery order is scheduled for completion by December 17, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. TAGRISSO is a targeted cancer therapy used in the treatment of non-small cell lung cancer, representing a specialty pharmaceutical product critical to military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp maintains a significant portfolio of competitive contract awards with the DLA, consistently demonstrating capability to fulfill federal medical supply requirements across multiple therapeutic domains including specialty medications, vaccines, and medical devices.
Quick answers
Who was awarded contract SPE2DR26F1LWD?
SPE2DR26F1LWD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F1LWD worth?
The government has obligated $11,237 on SPE2DR26F1LWD.
Is contract SPE2DR26F1LWD an order under another contract?
Yes. SPE2DR26F1LWD is a delivery order under SPE2DR25D2215, an indefinite delivery contract.
Was contract SPE2DR26F1LWD competed?
The extent of competition for SPE2DR26F1LWD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award